Eastwood Bio-Medical Canada Inc (EBM) — Capital Reinvestment Ratio

Latest as of July 2021: 0.27x

Eastwood Bio-Medical Canada Inc (EBM) has a Capital Reinvestment Ratio of 0.27x as of July 2021, meaning it reinvests 0% of its operating cash flow (CA$21.00K) in capital expenditures (CA$5.57K). See EBM net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

CA$21.00K

CAD

Capital Expenditures

CA$5.57K

CAD

Data as of

Jul 2021

Most recent filing

Annual Capital Reinvestment Ratio for Eastwood Bio-Medical Canada Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Eastwood Bio-Medical Canada Inc from None to None. For live market cap and broader valuation context, see Eastwood Bio-Medical Canada Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow